Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).
about
Alanine aminotransferase-old biomarker and new concept: a reviewDevelopment of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end productsStructural Analysis and Mutant Growth Properties Reveal Distinctive Enzymatic and Cellular Roles for the Three Major L-Alanine Transaminases of Escherichia coliObesity-Related Digestive Diseases and Their PathophysiologyPrevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994Newly diagnosed diabetes mellitus as a risk factor for serious liver diseaseMetabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.Gender and racial differences in nonalcoholic fatty liver disease.Alanine aminotransferase decreases with age: the Rancho Bernardo Study.The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.Relationship between serum leptin and chronic obstructive pulmonary disease in US adults: results from the third National Health and Nutrition Examination SurveyGeneralizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver diseaseMeta-analysis: vitamin D and non-alcoholic fatty liver disease.Association of Alanine Aminotransferase Levels (ALT) with the Hepatic Insulin Resistance Index (HIRI): a cross-sectional study.Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004.Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in saudi arabia.Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studiesNon-alcoholic fatty liver disease: The diagnosis and management.Metabolic syndrome and hepatic resection: improving outcomeAssociation between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.Serum levels of alanine aminotransferase decrease with age in longitudinal analysis.Relationship between Serum Aminotransferase Levels and Metabolic Disorders in Northern ChinaSerum vitamin D concentrations and unexplained elevation in ALT among US adults.Dyslipidemia in patients with nonalcoholic fatty liver disease.Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease.Association between metabolic syndrome and its individual components with viral hepatitis B.Non-alcoholic fatty liver disease and the metabolic syndrome: an update.One Year Follow-Up After Veriflex Phakic Intraocular Lenses Implantation for Correction of MyopiaCirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?Association between sonographic diagnosis of fatty liver with histopathologic abnormalities and liver biopsy findings in middle age patient with non-alcoholic fatty liver disease.Normal serum aminotransferase levels and the metabolic syndrome: Korean National Health and Nutrition Examination Surveys.Adherence to the Mediterranean diet moderates the association of aminotransferases with the prevalence of the metabolic syndrome; the ATTICA study.Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.Normal limit for serum alanine aminotransferase level and distribution of metabolic factors in old population of kalaleh, iran.Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.Low LDL-C and high HDL-C levels are associated with elevated serum transaminases amongst adults in the United States: a cross-sectional study.Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome.Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.
P2860
Q26828819-70BCDF82-E8FB-473F-B6BF-D52240ADC045Q26861308-DB730DD6-E349-4824-916C-13BBCE9ACE2BQ27684658-3FFAF0FD-B8DC-4FB2-BB38-2C6128A0A1B5Q28073381-5C3B4B4F-EC17-4395-9B65-45987693EF47Q28384968-C0BF5B93-3756-4772-83FE-9424ADA4D5A1Q30495922-51A6127C-9166-4CA3-AD55-820B93C29999Q30570152-38E30DDD-A915-4B71-A109-278844F1A64AQ33660001-20D0C124-C9D8-4AA6-B0D6-A32726EBF2D7Q33775683-5D1A7991-9375-43ED-AE32-5F7DF8A060B7Q34043671-4970FC44-D6BF-44C1-8DAC-02B24623949DQ34231911-1A6474CB-13D7-428D-84C2-B51984C45FF0Q34297858-B87FE0CE-081A-4D53-8802-086F55DF18E9Q34352252-B06AF368-E7C8-4C25-95F9-A39DC4CE6339Q34402713-06F8D2F9-BE00-4899-979B-6D21A61FDAECQ34407496-C3C8F47E-5456-41A0-9253-4FE3B14B51FFQ34782969-B05B7BC4-8378-498D-80AB-CBFF8C9675D4Q34942815-20FC0F80-F0BC-4BBD-A15F-EB8566D8F8D7Q35063759-AA37B126-A071-41EE-971B-275C8561D310Q35543956-56DF4600-CB40-4205-BF86-6C13BB7577DAQ35629684-847A2DEF-403D-4F0A-A927-726E2D3BEE0BQ35687497-DC46ADB3-C375-494A-B95C-CEB19CA332BFQ35782933-82CF27E3-F578-4AA4-A8D9-466DD390922DQ36348818-6F1C5868-4CDE-4A1D-82ED-D896684FF007Q36815947-1D456186-0BDA-43C2-AF93-634D5146A26CQ36845703-6467E13E-CCD7-444C-87CE-74F3FB8EDDF0Q37012994-F6D00BB0-DF61-4C4A-AC14-951029BD75DCQ37045953-BA3049E2-6935-42DA-B419-767D5BEE3919Q37054351-41161CBA-6050-48FC-8D1B-DA3FF7307DDDQ37104168-08C58427-C832-44CE-82CA-DEE2CE6BBDBDQ37141687-E1A61BD5-63A7-4F07-A96C-2693A749B9DEQ37157810-A5DF879C-D35E-4FEC-9C4E-CEA32EE9A88CQ37205639-28E1EFEF-7614-4E40-AEA8-49D7B98D308FQ37303393-02D8576A-3219-43B9-AC3C-9ECA7C9D7D20Q37345849-1D3CDA12-FC07-4D5B-86E1-406532FAB888Q37347728-B6C070DC-8CB6-4AD6-BD41-D471F4BF8866Q37405449-B25771C4-0CC5-4DF3-BE6F-BF06420355A0Q37483995-25F8782A-E07C-4313-8A4B-24E689A21D19Q37678998-235A70F7-1BB3-40CB-B42D-7E07ADA4E738Q37951502-4F0571F3-C9BB-456D-9B42-6ED93FE54E75Q38131030-AD76E901-5087-471B-9142-3C4DA180AD8F
P2860
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Unexplained elevations in alan ...... Nutrition Survey (NHANES III).
@en
Unexplained elevations in alan ...... al Health and Nutrition Survey
@nl
type
label
Unexplained elevations in alan ...... Nutrition Survey (NHANES III).
@en
Unexplained elevations in alan ...... al Health and Nutrition Survey
@nl
prefLabel
Unexplained elevations in alan ...... Nutrition Survey (NHANES III).
@en
Unexplained elevations in alan ...... al Health and Nutrition Survey
@nl
P1476
Unexplained elevations in alan ...... Nutrition Survey (NHANES III).
@en
P2093
Naga Chalasani
Suthat Liangpunsakul
P304
P356
10.1097/00000441-200503000-00001
P407
P577
2005-03-01T00:00:00Z